Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination

Multisystem Inflammatory Syndrome (MIS) is an uncommon systemic illness that occurs 4–6 weeks after primary infection with SARS-CoV-2. There are emerging reports of MIS arising following vaccination against SARS-CoV-2. We report a 16-year-old male with a multi system inflammatory condition meeting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hugh McGann, Patrick, Krim, Ahmed O.A., Green, Jared, Venturas, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Case Reports and Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843319/
https://www.ncbi.nlm.nih.gov/pubmed/35187466
http://dx.doi.org/10.1016/j.clinpr.2022.100139
Descripción
Sumario:Multisystem Inflammatory Syndrome (MIS) is an uncommon systemic illness that occurs 4–6 weeks after primary infection with SARS-CoV-2. There are emerging reports of MIS arising following vaccination against SARS-CoV-2. We report a 16-year-old male with a multi system inflammatory condition meeting the case definition for MIS following BTN162b2 mRNA SARS-CoV-2 (Pfizer BioNTech) vaccine with no other identifiable precipitant or evidence of primary infection with SARS-Cov-2.

Ejemplares similares